|

Petosemtamab Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 3: 2

Top Sponsors

  • Merus B.V.2

Indications

  • Head and Neck Squamous Cell Carcinoma2
  • Cancer2

Mobile, Alabama2 trials

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients

Site 160

Phase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Site 164

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.